Research advances in lipid-lowering therapy for hypertriglyceridemia pancreatitis with co-morbidities
The Expert Consensus on the Diagnosis and Management of Hypertriglyceridemia Acute Pancreatitis divides hypertriglyceridemic acute pancreatitis(HTG-AP)into two clinical subtypes according to TG levels,namely hypertriglyceridemic(HTG)pancreatitis(serum TG level>1000 mg/dl;TG levels are 500-1000 mg/dl and the serum is celiac)and acute pancreatitis(AP)with hypertriglyceridemia(TG levels of 150-500 mg/dl).Epidemiology suggests that triglyceride-rich lipoproteins(TRL)and their remnants are risk factors for cardiovascular disease and diabetes,while severe hypertriglyceridemia increases the risk of recurrent pancreatitis.Therefore,early and long-term triglyceride-lowering therapy for HTG-AP has its own specificity.This article reviews that new advances in the research and lipid-lowering treatment of HTG-AP.
万方数据
维普
